Vladimir Badmaev | Pharma | Industry Impact Award

Posted on by ScienceFather

Dr. Vladimir Badmaev  –  Pharma  –  Industry Impact Award

Alignment with Award Category

Dr. Badmaev’s research and innovations align seamlessly with the Industry Impact Award criteria. His pioneering work in natural pharma and smart drug development, along with his numerous patents and product contributions, make him a highly deserving candidate.

American Medical Holdings Inc. | United States

Profile

Orcid

Scopus

🎓Early Academic Pursuits 

Education and Training

Vladimir Badmaev, MD, PhD, embarked on his academic journey at the Medical Academy of Bialystok (AMB) in Poland, where he graduated in 1975. His early academic years laid a strong foundation in medical sciences, leading him to specialize in clinical and anatomical pathology. He pursued his specialization at Kings County Hospital, New York, and Downstate Medical Center, New York, between 1982 and 1985. During this period, he honed his expertise in understanding disease mechanisms and diagnostic techniques. Additionally, in 1978, he obtained his PhD in immunopharmacology from AMB, reflecting his deep interest in the interaction between the immune system and pharmacological agents. His academic credentials positioned him as a leader in integrative medicine, combining traditional knowledge with scientific advancements.

💼Professional Endeavors 

Academic Positions

Dr. Badmaev’s professional career has been defined by his dedication to bridging traditional botanical medicine with modern pharmacological science. In 1984, he established the Badmaev Natural Drug Foundation, an organization committed to exploring the therapeutic potential of natural compounds. Later, in 2009, he founded American Medical Holdings Inc. in Staten Island, New York, to advance the development of nutraceuticals and natural pharmaceutical products. Through these initiatives, he has played a crucial role in integrating the principles of traditional medicine with contemporary scientific research. His company, www.badmaevtradition.com, stands as a testament to his lifelong commitment to safe and effective alternative medicine solutions.

📚Contributions and Research Focus on Pharma

Dr. Badmaev has dedicated his career to the research and development of nutraceuticals and natural pharmaceutical products. He conceptualized the Interactive Nutrients Process (INP), a method that integrates the knowledge of botanicals with pharmacological science to develop “smart drugs” using artificial intelligence. His work has been instrumental in the advancement of various nutraceutical formulations, including C3Complex® (Sabinsa), Gugulipid® (Sabinsa), SeleniumSelect® (Sabinsa), Lactospore® (Sabinsa), Xanthigen® (PLThomas), RhodioLife® (PLThomas/Polyphenoles Naturales), Zembrin® (PLThomas/HGH), 5-Loxin®/Apres-Flex® (PLThomas), and MenaQ7® (NattoPharma). Furthermore, he has been actively involved in developing natural therapeutics such as Adaptrin®, GreenSelenium®, TurmericImmune®, SlimTrym®, and FB3® under American Medical Holdings Inc. His recent work focuses on the natural ginger phenolic derivative, 6-Shogaol, for managing iron overload and early-stage myelodysplastic syndromes (MDS). This breakthrough has resulted in a US patent, No.: US 10,864,174 B2 (2017), along with 11 related patents worldwide (2017-2024).

🏆Accolades and Recognition 

Between 1999 and 2009, Dr. Badmaev was the runner-up or recipient of four New Jersey R&D Council Thomas Alva Edison Awards. These accolades were awarded in recognition of his contributions to scientific research and patent innovations, including US patents #5,536,506, #5,804,596, #6,849,645, and #7,063,861. His extensive work in the field of nutraceutical research has earned him international recognition, leading to collaborations and multiple patent approvals in various countries, including Australia, Canada, New Zealand, Mexico, Brazil, South Africa, the European Community, Japan, Korea, India, and China.

🌍 Impact and Influence 

Community Impact

Dr. Badmaev’s influence extends beyond research and development. His contributions to literature have enriched the understanding of traditional medicine’s integration with modern healthcare. In 1999, he authored a chapter on Tibetan medicine in a medical textbook for students and healthcare professionals, edited by Wayne Jonas and Jeffrey Levine. A decade later, in 2009, he contributed to a chapter on curcuminoids in a book on alternative treatments in medicine by Raymond Cooper and Fredi Kronenberg. His scholarly work has provided valuable insights into the therapeutic applications of botanical medicine.

🔮Legacy and Future Contributions 

Dr. Badmaev’s contributions have left a lasting impact on the field of integrative medicine. His membership in esteemed medical and scientific societies, including the International Society of Immunopharmacology (1982), the American Association of Clinical Pathologists (1983), the American Medical Association (1984), and the Research and Development Council of New Jersey (1996), underscores his commitment to advancing medical science. His ongoing research into the development of AI-driven “smart drugs” signifies his vision for the future of medicine.

 

Conclusion

Vladimir Badmaev, MD, PhD, has dedicated his career to harmonizing traditional botanical medicine with scientific innovation. His pioneering research, extensive patent portfolio, and contributions to the nutraceutical industry exemplify his lifelong mission to develop safe and effective medical solutions. As he continues his work on AI-integrated nutraceuticals, his legacy serves as an inspiration for future generations in the field of integrative medicine.

📚Publications

Interactive Nutrient Process (INP) in a Generative AI of a New Drug—6-Shogaol as a Potential Case

Authors: Vladimir Badmaev

Journals: Drug Design, Development and Therapy

Vitamin K Insufficiency in the Indian Population: Pilot Observational Epidemiology Study

Authors: Rama Vaidya; Ashok D B Vaidya; Jayesh Sheth; Shashank Jadhav; Umakant Mahale; Dilip Mehta; Janusz Popko; Vladimir Badmaev; Sidney J Stohs

Journals: JMIR Public Health and Surveillance

Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review

Authors: Soo Liang Ooi; Ron Campbell; Sok Cheon Pak; Terry Golombick; Arumugam Manoharan; Raj Ramakrishna; Vladimir Badmaev; Janet Schloss

Journals: Integrative Cancer Therapies

Proof‐of‐Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase‐4 in Cognitively Healthy Subjects: Implications for Alzheimer’s Dementia

Authors: Simon Chiu; Nigel Gericke; Michel Farina-Woodbury; Vladimir Badmaev; Hana Raheb; Kristen Terpstra; Joalex Antongiorgi; Yves Bureau; Zack Cernovsky; Jirui Hou et al.

Journals: Evidence-Based Complementary and Alternative Medicine

Soumendu Patra | Cancer biology | Best Researcher Award

Posted on by ScienceFather

Mr. Soumendu Patra – Cancer biology – Best Researcher Award

Alignment with Award Category

Soumendu Patra’s achievements align with categories recognizing excellence in scientific research, innovation, and academic contributions. His expertise in biosensor technology, molecular biology, and microbiology, coupled with his impactful research projects and publications, make him a strong contender for awards in microbiological research, biomedical innovation, and environmental biotechnology.

 

Raiganj University | India

Profile

Orcid

Scopus

🎓Early Academic Pursuits 

Education and Training

Soumendu Patra’s academic journey is marked by a strong foundation in microbiology. His pursuit of higher education began with a Bachelor of Science (B.Sc.) in Microbiology from Midnapore College (Autonomous), affiliated with Vidyasagar University, India, where he graduated in July 2019. Demonstrating his commitment to the field, he furthered his education by obtaining a Master of Science (M.Sc.) in Microbiology from West Bengal State University in 2021, achieving an impressive CGPA of 9.31/10. His academic excellence and dedication to microbiological research paved the way for his current Ph.D. studies at Raiganj University, where he is focused on biosensor technology for detecting HPV-associated cervical cancer.

💼Professional Endeavors 

Academic Positions

Soumendu Patra has gained substantial research experience throughout his academic career. Currently, he is a Research Scholar in the Department of Microbiology at Raiganj University, working on a thesis titled “Polydiacetylene-Liposome Based Biosensor for Rapid Detection in HPV-Associated Cervical Cancer.” Prior to this, he contributed significantly as a Project Assistant in a research project funded by the Department of Biotechnology, Government of India, focused on developing an early screening kit for HPV-associated cervical cancer.

📚Contributions and Research Focus on Cancer biology

Soumendu Patra’s research primarily revolves around microbiology, molecular biology, and biosensor technology. His ongoing Ph.D. research aims to develop a polydiacetylene-liposome-based biosensor for detecting HPV-associated cervical cancer, a project with immense implications for early cancer diagnosis.

Additionally, his research projects include:

  • HPV-Associated Cervical Cancer Early Screening Kit Development – This project involves screening and confirming cervical cancer patients through urine and vaginal swab sample collection, ELISA testing, sensor fabrication, and validation.
  • Anti-cancerous Flavonoids as Potential Inhibitors for Dengue Virus Replication – An in-silico study analyzing the interaction between anticancer flavonoids and dengue virus proteins using molecular docking and molecular dynamics simulations.
  • Isolation and Characterization of Multi-Metal Resistant Bacteria from Wastewater – A study on screening heavy metal-resistant bacteria for potential use in bioremediation.

🏆Accolades and Recognition 

Soumendu Patra has gained recognition through his participation in numerous conferences, workshops, and training sessions. Notable among these are: A poster presentation on “Coronavirus: Myths and Facts” at the UGC-SAP (DRS-II) Sponsored National Conference at Kalyani University. Participation in the UGC-sponsored National Seminar on “Role of Microbes for Sustainable Agriculture and Environment.” Training on metagenomics conducted by the Department of Microbiology at West Bengal State University in collaboration with IIT Madras.

🌍 Impact and Influence 

Community Impact

Soumendu Patra’s research has the potential to revolutionize early disease detection and environmental sustainability. His work on biosensors for HPV detection can significantly enhance cancer diagnosis, improving patient outcomes. Similarly, his contributions to microbial bioremediation can pave the way for innovative environmental cleanup strategies. His collaborations with esteemed researchers and institutions further amplify the impact of his work on global scientific advancements.

🔮Legacy and Future Contributions 

As a dedicated researcher, Soumendu Patra’s legacy will be shaped by his continued efforts in microbiology and biosensor technology. His work promises advancements in medical diagnostics and environmental biotechnology. He aspires to contribute to academia and industry by developing novel diagnostic tools and sustainable microbial applications, fostering scientific progress and public health improvements.

Conclusion

Soumendu Patra’s academic and research trajectory reflects his dedication to scientific excellence. From his foundational education in microbiology to his pioneering research in biosensors and microbial bioremediation, he has consistently demonstrated a commitment to advancing knowledge and solving real-world problems. His contributions to HPV detection and environmental sustainability position him as a promising researcher whose work will leave a lasting impact on both medical and environmental sciences.

📚Publications

HPV and Male Cancer: Pathogenesis, Prevention and Impact
Authors: Soumendu Patra; Harshita Shand; Sayan Ghosal; Suvankar Ghorai

Journals: Journal of the Oman Medical Association

Fatty acid binding protein as a new age biomarker

Authors: Harshita Shand; Soumendu Patra; Suvankar Ghorai

Journals: Clinica Chimica Acta

Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger Problems

Authors: Ghorai, Suvankar; Shand, Harshita; Patra, Soumendu; Panda, Kingshuk; Santiago, Maria J.; Rahman, Md. Sohanur; Chinnapaiyan, Srinivasan; Unwalla, Hoshang J.

Journals: Pharmaceutics

Plant response–driven fertilizer nutrient development

Authors: Harshita Shand; Rittick Mondal; Pankaj Mandal; Soumendu Patra; Suvankar Ghorai; Amit Kumar Mandal

Journals: Essential Minerals in Plant-Soil Systems

 

Nathalie | Cancer research | Women Researcher Award

Posted on by ScienceFather

Dr. Nathalie – Cancer research – Women Researcher Award

Alignment with Award Category

Dr. Mazure’s groundbreaking research in cancer biology, particularly her work on metabolic shifts in cancer cells and the molecular mechanisms of cell death resistance, aligns perfectly with the award category recognizing excellence in scientific research in the field of cancer biology. Her contributions to understanding cancer metabolism, hypoxia, and the role of primary cilia in tumor survival have had far-reaching implications for cancer treatment and drug development.

 

CNRS | France

Profile
orcid

🎓Early Academic Pursuits 

Education and Training

Nathalie Mazure was born on July 8, 1966, in Issy-les-Moulineaux, France. Her academic journey began with a strong foundation in biological sciences. She earned her PhD in 1994 from the University of Technology of Compiègne, focusing on microbial genetics. This early research sparked her passion for exploring the molecular mechanisms underlying cellular functions, which would later become the central theme of her academic and professional pursuits.

💼Professional Endeavors 

Academic Positions

Dr. Mazure’s career spans multiple academic and research positions, primarily centered around cancer research, molecular biology, and cellular metabolism. Since January 2024, she has been co-directing Team 5 “Cancer, Metabolism and Microenvironment” at the Institut C3M (INSERM U1065) and the University of Nice-Sophia Antipolis. Her research theme focuses on critical areas such as cancer, cell death resistance, hypoxia, and the role of VDAC1 and primary cilium in these processes.

📚Contributions and Research Focus on Cancer research

Dr. Mazure’s research has been pivotal in exploring the molecular mechanisms involved in cancer progression, particularly in how tumor cells survive in low-oxygen (hypoxic) environments. Her work on VDAC1, a mitochondrial protein, has led to significant insights into cell death resistance in cancer cells. The development of a predictive biomarker for chemoresistance, based on the molecular interactions between VDAC1 and other cellular components, is one of her notable contributions. In addition to her work on cancer cell metabolism, Dr. Mazure has been a key figure in advancing our understanding of primary cilium function in cancer cells. This organelle, often overlooked in traditional cancer research, plays a critical role in cellular signaling pathways that regulate cell growth and survival. Her interdisciplinary approach, combining cell biology, molecular genetics, and cancer research, has led to a deeper understanding of the metabolic shifts that occur in cancer cells under stress.

🏆Accolades and Recognition 

Throughout her illustrious career, Dr. Mazure has received numerous accolades, underscoring her significant contributions to cancer research. She was awarded the prestigious Laureate prize from the Fondation Aventis in 2001 for her innovative research in human health. She was also the recipient of the Madeleine and Jean Schaeverbeke Prize in 2010, awarded by the Fondation de France, recognizing her exceptional work in cancer biology.

🌍 Impact and Influence 

Community Impact

Dr. Mazure’s research has had a profound impact on both the scientific community and clinical applications. Her discoveries related to cancer cell metabolism and resistance to cell death have opened new avenues for therapeutic interventions targeting the metabolic pathways that tumors exploit for survival. Her work has influenced cancer therapies, particularly those aimed at overcoming resistance to chemotherapy and improving the efficacy of existing treatments.

🔮Legacy and Future Contributions 

As Dr. Mazure continues to lead her research team at C3M, her future contributions are poised to shape the next generation of cancer therapies. Her current focus on the interplay between cancer metabolism and the immune system, as well as her ongoing efforts to understand the role of hypoxia in cancer progression, will likely lead to the development of more targeted and personalized cancer treatments.

Conclusion

Nathalie Mazure’s career has been defined by a relentless pursuit of scientific knowledge, a commitment to improving cancer treatments, and a strong dedication to fostering international collaborations. Through her research, leadership, and mentoring, she has made a significant impact on the field of cancer biology and beyond. As she continues to push the boundaries of scientific discovery, her legacy will undoubtedly inspire future generations of researchers and clinicians dedicated to improving human health

📚Publications

YAP1 modulation of primary cilia‐mediated ciliogenesis in 2D and 3D prostate cancer models

Authors: Yingbo Guo; Mathilde Dupart; Marie Irondelle; Pascal Peraldi; Frederic Bost; Nathalie M. Mazure
Journals: FEBS Letters

CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism

Authors: Vincent Rondeau; Maria Kalogeraki; Lilian Roland; Zeina Abou Nader; Vanessa Gourhand; Amélie Bonaud; Julia Lemos; Mélanie Khamyath; Clémentine Moulin; Bérénice Schell et al.
Journals: Science Signaling

Vitiligo auto‐immune response upon oxidative stress‐related mitochondrial DNA release opens up new therapeutic strategies

Authors: Ana Sant’Anna-Silva; Thomas Botton; Andrea Rossi; Jochen Dobner; Hanene Bzioueche; Nguyen Thach; Lauriane Blot; Sophie Pagnotta; Konrad Kleszczynski; Kerstin Steinbrink et al.
Journals: Clinical and Translational Medicine